AVAH vs MMS

For growth investors, Aveanna Healthcare Holdings Inc.

(AVAH) is the stronger pick with 20. 2% revenue growth year-over-year, versus 2. 4% for Maximus, Inc. (MMS). Aveanna Healthcare Holdings Inc. (AVAH) offers the better valuation at 6. 6x trailing P/E (12. 0x forward), making it the more compelling value choice. Analysts rate Maximus, Inc. (MMS) a "Buy" — based on 16 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Aveanna Healthcare Holdings Inc.

(AVAH) is the cheapest at 6. 6x versus Maximus, Inc. at 12. 1x. On forward P/E, Maximus, Inc. is actually cheaper at 7. 8x — notably different from the trailing picture, reflecting expected earnings growth.

Over the past 5 years, Maximus, Inc.

(MMS) delivered a total return of -20. 4%, compared to -39. 8% for Aveanna Healthcare Holdings Inc. (AVAH). Over 10 years, the gap is even starker: MMS returned +39. 7% versus AVAH's -42. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Maximus, Inc.

(MMS) is the lower-risk stock at 0. 72β versus Aveanna Healthcare Holdings Inc. 's 1. 40β — meaning AVAH is approximately 93% more volatile than MMS relative to the S&P 500. On balance sheet safety, Maximus, Inc. (MMS) carries a lower debt/equity ratio of 86% versus 7% for Aveanna Healthcare Holdings Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Aveanna Healthcare Holdings Inc.

(AVAH) is pulling ahead at 20. 2% versus 2. 4% for Maximus, Inc. (MMS). On earnings-per-share growth, the picture is similar: Aveanna Healthcare Holdings Inc. grew EPS 1952% year-over-year, compared to 10. 4% for Maximus, Inc.. Over a 3-year CAGR, AVAH leads at 10. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Aveanna Healthcare Holdings Inc.

(AVAH) is the more profitable company, earning 9. 2% net margin versus 5. 9% for Maximus, Inc. — meaning it keeps 9. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AVAH leads at 10. 9% versus 10. 6% for MMS. At the gross margin level — before operating expenses — AVAH leads at 33. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, Maximus, Inc.

(MMS) trades at 7. 8x forward P/E versus 12. 0x for Aveanna Healthcare Holdings Inc. — 4. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MMS: 65. 0% to $110. 00.

In this comparison, MMS (1.

8% yield) pays a dividend. AVAH does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Maximus, Inc.

(MMS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 72), 1. 8% yield). Both have compounded well over 10 years (MMS: +39. 7%, AVAH: -42. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (AVAH (Healthcare) and MMS (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: AVAH is a small-cap high-growth stock; MMS is a small-cap deep-value stock. MMS pays a dividend while AVAH does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.